NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-MODAFINIL TABLETS Contains the active ingredient modafinil
Continue reading »
APO-Olmesartan
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-OLMESARTAN Contains the active ingredient olmesartan medoxomil
Continue reading »
APO-Pravastatin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-PRAVASTATIN TABLETS Contains the active ingredient pravastatin
Continue reading »
DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board
Continue reading »